Mon, Mar 3, 10:00 PM (53 days ago)
Agilent Technologies, Inc. (NYSE: A) reported a modest revenue increase of 1% to $1,681 million for the quarter ending January 31, 2025, driven by growth in the Life Sciences and Diagnostics Markets segment, which rose 4%. However, the Applied Markets segment saw a 4% decline. Net income decreased to $318 million from $348 million year-over-year, with a diluted EPS of $1.11. Operating income fell by 2% to $376 million, reflecting a slight decline in operating margin to 22.4%. Cash flow from operations was $431 million, down from $485 million, influenced by higher cash outflows for variable pay and tax payments. Total assets increased to $11,914 million, with cash and equivalents at $1,467 million. The company repurchased 649,857 shares for $90 million under its $2 billion repurchase program. Agilent is navigating uncertainties in global markets, inflationary pressures, and foreign currency impacts, which negatively affected revenue growth by 2 percentage points. The firm remains focused on innovation and operational efficiency to enhance customer experience and drive future growth, despite challenges in capital spending and market demand.